First Monday with Turbine & Interactive Venture Partners
First Monday is back on April 13 and we’re talking Series B scale!
We’re hosting a fireside chat with Szabolcs Nagy (CEO, Turbine) and Mary Alcantara (Partner, Interactive Venture Partners) to unpack one of the most exciting Hungarian funding stories in biotech right now:
Turbine just closed a $25M Series B, led by Interactive Venture Partners, with participation from Beiersdorf Venture Capital and continued support from MSD Global Health Innovation, Accel, and Mercia.
But this isn’t just a “headline round.”
Turbine is scaling its Virtual Lab — a no-code platform that lets pharma teams run AI-powered, virtual biological experiments to pressure-test ideas early, learn faster, and make better calls before time and budget disappear in the wet lab.
And the traction goes beyond the raise: Turbine also announced a new immunology partnership with a Top 10 pharma company, expanding its reach beyond oncology into a broader set of therapeutic areas.
In a world where wet labs are expensive, slow, and capacity-limited, the real advantage is simple:
more shots on goal, with higher confidence.
We’ll go behind the scenes on:
what it takes to win conviction for a Series B in today’s market
how investors evaluate frontier platforms at scale
and what’s next when computation starts reshaping biology
If you’re building in AI, biotech, or deep tech — you’ll want to be in the room.
Schedule
• 6:00–6:30 Registration
• 6:30–6:45 Introduction
• 6:45–7:45 Fireside chat: Turbine & Interactive Venture Partners
• 7:45–8:00 Q&A
• 8:00–9:30 Drinks, mingling & networking